Reneo Pharmaceuticals, Inc. (RPHM)

NASDAQ: RPHM · IEX Real-Time Price · USD
1.660
+0.010 (0.61%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Total Valuation

RPHM has a market cap or net worth of $55.30 million. The enterprise value is -$69.18 million.

Market Cap 55.30M
Enterprise Value -69.18M

Important Dates

The last earnings date was Thursday, March 28, 2024, before market open.

Earnings Date Mar 28, 2024
Ex-Dividend Date n/a

Share Statistics

RPHM has 33.31 million shares outstanding. The number of shares has increased by 38.01% in one year.

Shares Outstanding 33.31M
Shares Change (YoY) +38.01%
Shares Change (QoQ) +11.89%
Owned by Insiders (%) 3.01%
Owned by Institutions (%) 82.41%
Float 14.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.48
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.49, with a Debt / Equity ratio of 0.01.

Current Ratio 9.49
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -62.10% and return on invested capital (ROIC) is -62.55%.

Return on Equity (ROE) -62.10%
Return on Assets (ROA) -55.60%
Return on Capital (ROIC) -62.55%
Revenue Per Employee n/a
Profits Per Employee -$1.23M
Employee Count 55
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -69.37% in the last 52 weeks. The beta is 0.24, so RPHM's price volatility has been lower than the market average.

Beta (1Y) 0.24
52-Week Price Change -69.37%
50-Day Moving Average 1.65
200-Day Moving Average 5.07
Relative Strength Index (RSI) 48.06
Average Volume (30 Days) 356,068

Short Selling Information

The latest short interest is 2.82 million, so 8.48% of the outstanding shares have been sold short.

Short Interest 2.82M
Short Previous Month 2.59M
Short % of Shares Out 8.48%
Short % of Float 19.28%
Short Ratio (days to cover) 12.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -72.61M
Pretax Income -67.43M
Net Income -67.43M
EBITDA -66.83M
EBIT -67.43M
Earnings Per Share (EPS) -$2.37
Full Income Statement

Balance Sheet

The company has $125.61 million in cash and $1.14 million in debt, giving a net cash position of $124.48 million or $3.74 per share.

Cash & Cash Equivalents 125.61M
Total Debt 1.14M
Net Cash 124.48M
Net Cash Per Share $3.74
Equity / Book Value 114.94M
Book Value Per Share 3.45
Working Capital 115.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.54 million and capital expenditures -$446,000, giving a free cash flow of -$59.99 million.

Operating Cash Flow -59.54M
Capital Expenditures -446,000
Free Cash Flow -59.99M
FCF Per Share -$1.77
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RPHM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -38.01%
Shareholder Yield -38.01%
Earnings Yield -121.95%
FCF Yield -108.48%

Analyst Forecast

The average price target for RPHM is $11.46, which is 590.36% higher than the current price. The consensus rating is "Buy".

Price Target $11.46
Price Target Difference 590.36%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2